PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
14-May-2024 Carthera receives Orphan Drug Designation from US and EU authorities for carboplatin in malignant glioma Andrew Lloyd Associates
14-May-2024 BioWin and MEDVIA sign first strategic collaboration between health clusters in Wallonia and Flanders Andrew Lloyd Associates
13-May-2024 Sartorius Collaborates with Sanofi to Commercialize End-To-End Platform for Downstream Process Intensification Sartorius
13-May-2024 Aqilion expands its pipeline Aqilion
13-May-2024 Breakthrough in Cancer Care After Entia Gets Go-Ahead for World’s First At-Home Blood Monitoring Solution for Patients Entia
13-May-2024 Maria Alfaiate appointed new Executive Vice President Commercial and Corporate Strategy at Lundbeck H. Lundbeck A/S
13-May-2024 Macomics and IFOM (the AIRC Institute of Molecular Oncology) Announce Macrophage Scientific Collaboration Macomics Ltd
13-May-2024 SYMBICORT (budesonide/formoterol) TURBOHALER 200/6® ACCEPTED FOR USE IN SCOTLAND AS RELIEVER THERAPY FOR PATIENTS WITH MILD ASTHMA AGED 12 YEARS AND OLDER AstraZeneca
13-May-2024 Research shows that ‘softer’ proteins can cross into the nucleus quicker The Francis Crick Institute
11-May-2024 Alfa Chemistry Offers a Comprehensive Range of Biological Filtration Products Alfa Chemistry
10-May-2024 MODERNA WELCOMES THE SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE TO THE MODERNA INNOVATION AND TECHNOLOGY CENTRE IN OXFORDSHIRE Moderna
10-May-2024 New EU directive will require UK businesses trading with the EU to enforce ESG compliance within their supply chains INVERTO
10-May-2024 Bloomsbury Genetic Therapies showcases its First Preclinical Data on Parkinson’s Disease Program at the American Society of Gene & Cell Therapy 2024 Annual Meeting Bloomsbury Genetic Therapies Limited
10-May-2024 Commit Biologics launches with €16m seed financing to pioneer complement system activation to treat cancer and autoimmune disease Commit Biologics
09-May-2024 Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines Infinitopes Precision Immunomics
09-May-2024 EDWARDS LAUNCHES THE SAPIEN 3 ULTRA RESILIA VALVE WITH TECHNOLOGY TO ENHANCE DURABILITY Edwards Lifesciences
09-May-2024 PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting PureTech Health plc
09-May-2024 Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2024 Nxera Pharma
09-May-2024 New Report Reveals The Extent of Life Science Sector's Perfect Storm Medicines Discovery Catapult (MDC)
09-May-2024 Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia MedinCell